Stay updated with breaking news from Cell Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Findings from St. Jude Children's Research Hospital are moving the field of cancer immunotherapy one step closer to treating brain and solid tumors.
Laboratory findings have set the stage for a clinical trial investigating a drug for pancreatic cancer that has spread to the liver.
Pancreatic cancer is tricky to manage because it spreads easily and early, and the tumors have a unique biological makeup.
<p>A new scientific finding at the University of Rochester is the foundation for the first clinical trial in the U.S. to study an experimental drug's ability to fight pancreatic cancer with metastasis to the liver. The trial is expected to launch early in 2024 at UR's Wilmot Cancer Institute. </p> <p> </p> <p> </p>
Get latest articles and stories on Science at LatestLY. Pancreatic cancer is difficult to treat because it spreads quickly and has a distinct biochemical makeup. However, researchers achieved a significant advance by discovering the genetic changes that occur during tumour migration -- and they also discovered a medication that may block the process. Science News | Pancreatic Cancer Discovery Opens Door for New Clinical Trial: Research.